A year ago, Oklo and NuScale were highly recommended as buys amid optimism for small modular reactors (SMRs) in nuclear energy. Since then, Oklo's stock dropped 81.4% and NuScale's fell 85.8%, reflecting ongoing execution risks and lack of commercial power sales. Both companies hold billions in cash and show technical progress, but definitive contracts and revenue remain absent. Analysts still see upside potential if key projects and agreements materialize, but investors should watch cash burn, share dilution, and binding contracts closely before expecting a stock recovery.
Oklo and NuScale continue to face challenges as seen in their trading activity on Pluang. Oklo trades at USD 31.71 with a slight 0.22% decrease, while NuScale is priced at USD 6.47, down 0.38%. These figures are current as of Oct 14, 2026, 19:12 WIB.
